Literature DB >> 1946181

Evaluation of a new computerized psychomotor test battery: effects of alcohol.

E J Nuotto1, K T Korttila.   

Abstract

In order to better evaluate the effects of centrally active drugs, a new computer based set of psychomotor tests was developed. Compared to the older apparati, the new set is very flexible and easy to operate allowing the measurement of hand/eye coordination, attention and several types of reaction skills. To evaluate the sensitivity and usefulness of the new tests, the effects of alcohol (oral doses of 0.5 g/kg and 1.0 g/kg) were studied in twelve healthy volunteers. The peak blood alcohol concentration after the larger dose was 0.86 g/l, and the effects were clearly seen with all new tests. The smaller dose of alcohol gave 0.33 g 1 peak blood alcohol concentration and it impaired significantly only coordination at 1 hr after drinking. The results suggest that the new tests are at least as sensitive and reliable as older psychomotor tests detecting the effects of central depressant agents. The advantage of the new tests is that they are easy to operate and easy to modify without any specific programming skills. Because they can be used with a computer which is easy to transport, these tests are suitable for use in clinical areas to conduct studies with patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946181     DOI: 10.1111/j.1600-0773.1991.tb01253.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  17 in total

1.  Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Pharmacol Biochem Behav       Date:  2011-08-23       Impact factor: 3.533

2.  Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.

Authors:  James P Zacny; Sandra Gutierrez
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

3.  Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Drug Alcohol Depend       Date:  2012-02-25       Impact factor: 4.492

Review 4.  Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation.

Authors:  S D Ferrara; S Zancaner; R Giorgetti
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

5.  Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Pharmacol Biochem Behav       Date:  2011-11-04       Impact factor: 3.533

6.  Subjective and behavioral responses to intravenous fentanyl in healthy volunteers.

Authors:  J P Zacny; J L Lichtor; J G Zaragoza; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers.

Authors:  J P Zacny; J L Lichtor; W Binstock; D W Coalson; T Cutter; D C Flemming; B Glosten
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sex.

Authors:  James P Zacny; Melinda Drum
Journal:  Drug Alcohol Depend       Date:  2009-11-30       Impact factor: 4.492

9.  Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.

Authors:  James P Zacny; Stephanie A Lichtor
Journal:  Psychopharmacology (Berl)       Date:  2007-09-27       Impact factor: 4.530

10.  The subjective, behavioral and cognitive effects of subanesthetic concentrations of isoflurane and nitrous oxide in healthy volunteers.

Authors:  J P Zacny; G Sparacino; P Hoffmann; R Martin; J L Lichtor
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.